BCRX logo

BioCryst Pharmaceuticals, Inc. (BCRX)

Profile

Full Name

BioCryst Pharmaceuticals, Inc.

Ticker

NASDAQ: BCRX

Exchange

NASDAQ

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

United States

IPO

March 4, 1994

Indexes

Not included

Website

http://www.biocryst.com

Employees

580

Key Details

Price

$8.76(-1.35%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$450.71M(+36.00% YoY)

Annual EPS

-$0.43(+63.56% YoY)

PE ratio

-

Next earnings date

Aug 5, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $8.76
    BCRX price is $8.76

    30-Day Relative Volume

    0.57
    BCRX 30-day relative volume is 0.57

    Price Performance

    Price Most recent change

    -1.35%
    BCRX price was down -1.35% on Jul 11, 2025

    Price YTD change

    +16.49%
    BCRX price is up +16.49% since January 1st

    Price 1-year change

    +24.43%
    BCRX price is up +24.43% year-on-year

    Price 3-year change

    -21.29%
    BCRX price is down -21.29% over the past 3 years

    Price Range

    Price All-time high

    $37.25
    BCRX price is currently -76.48% below its historical high of $37.25

    Price 3-year low

    $4.03
    BCRX price is currently +117.37% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $1.83B
    BCRX market capitalization is $1.83 billion

    Market cap 3-year change

    -11.4%
    BCRX market capitalization is down -11.4% over the past 3 years

    Market cap All-time high

    $3.65B
    BCRX market capitalization is currently -49.77% below its historical high of $3.65 billion

    Market cap sector rank

    80.91%
    BCRX market capitalization is higher than 80.91% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +1.27%
    BCRX shares outstanding is up +1.27% year-on-year

    Shares Outstanding 3-Year Change

    +12.58%
    BCRX shares outstanding is up +12.58% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.77
    BCRX beta is 0.77

    200-day SMA

    $8.32
    BCRX price is currently +5.28% above its 200-day simple moving average

    50-day SMA

    $10.01
    BCRX price is currently -12.52% below its 50-day simple moving average

    RSI

    31.54
    BCRX 14-day relative strength index is 31.54

    Volume

    0.57
    BCRX 30-day relative volume is 0.57

    ATR

    $0.34
    BCRX average true range is $0.34

    10-day Historical Volatility

    33.44%
    BCRX 10-day historical volatility is 33.44%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $450.71M
    BCRX annual revenue is $450.71 million

    Revenue Analysts estimate

    $608.13M
    BCRX annual revenue is currently -25.89% lower than the consensus analysts' forecast

    Revenue 1-year change

    +36%
    BCRX annual revenue is up +36% year-on-year

    Revenue Sector rank

    72.97%
    BCRX annual revenue is higher than 72.97% of companies in Healthcare sector

    EPS

    EPS

    -$0.43
    BCRX annual earnings per share is -$0.43

    EPS Analysts estimate

    $0.14
    BCRX annual earnings per share is currently -410.02% lower than the consensus analysts' forecast

    EPS 1-year change

    +63.56%
    BCRX annual earnings per share is up +63.56% year-on-year

    EPS Sector rank

    69.72%
    BCRX annual earnings per share is higher than 69.72% of companies in Healthcare sector

    Profit

    Gross profit

    $438.23M
    BCRX annual gross profit is $438.23 million

    Gross margin

    97.23%
    BCRX annual gross profit margin is 97.23%

    Operating profit

    -$2.54M
    BCRX annual operating income is -$2.54 million

    Operating margin

    -0.56%
    BCRX annual operating profit margin is -0.56%

    Net income

    -$88.88M
    BCRX annual net profit is -$88.88 million

    Net margin

    -19.72%
    BCRX annual net profit margin is -19.72%

    Expenses

    Total expenses

    $453.25M
    BCRX annual total expenses is $453.25 million

    Operating expenses

    $440.77M
    BCRX annual total operating expenses is $440.77 million

    Cost of goods sold

    $12.48M
    BCRX annual cost of goods sold is $12.48 million

    Selling, general & administrative expenses

    $266.13M
    BCRX annual SGA is $266.13 million

    Depreciation and amortization

    $1.25M
    BCRX annual depreciation & amortization is $1.25 million

    Interest expense

    $98.52M
    BCRX annual interest expense is $98.52 million

    Income tax

    $1.93M
    BCRX annual income tax is $1.93 million

    EBIT & EBITDA

    EBIT

    $11.56M
    BCRX annual earnings before interest & taxes is $11.56 million

    EBITDA

    $12.81M
    BCRX annual EBITDA is $12.81 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $490.42M
    BCRX annual total assets is $490.42 million

    Non current assets

    $68.45M
    BCRX annual long term assets is $68.45 million

    Current assets

    $421.97M
    BCRX annual total current assets is $421.97 million

    Cash and cash equivalents

    $104.71M
    BCRX annual cash & cash equivalents is $104.71 million

    Accounts receivable

    $79.07M
    BCRX annual accounts receivable is $79.07 million

    Inventory

    $8.09M
    BCRX annual inventory is $8.09 million

    Liabilities

    Total liabilities

    $966.35M
    BCRX annual total liabilities is $966.35 million

    Long term liabilities

    $805.97M
    BCRX annual total long term liabilities is $805.97 million

    Current liabilities

    $160.38M
    BCRX annual total current liabilities is $160.38 million

    Accounts payable

    $11.64M
    BCRX annual accounts payable is $11.64 million

    Debt

    Total debt

    $808.74M
    BCRX annual total debt is $808.74 million

    Total debt 1-year change

    -1.99%
    BCRX annual total debt is down -1.99% year-on-year

    Long term debt

    $805.97M
    BCRX annual long term debt is $805.97 million

    Short term debt

    $2.77M
    BCRX annual short term debt is $2.77 million

    Equity & Capital

    Shareholders equity

    -$475.93M
    BCRX annual stockholders equity is -$475.93 million

    Book value

    -$475.93M
    BCRX annual book value is -$475.93 million

    Retained earnings

    -$1.77B
    BCRX annual retained earnings is -$1.77 billion

    Working capital

    $261.58M
    BCRX annual working capital is $261.58 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$52.02M
    BCRX annual cash flow from operations is -$52.02 million

    Cash from operations 1-year change

    +45.32%
    BCRX annual cash flow from operations is up +45.32% year-on-year

    Cash from investing

    $52.59M
    BCRX annual cash flow from investing activities is $52.59 million

    Cash from investing 1-year change

    +140%
    BCRX annual cash flow from investing activities is up +140% year-on-year

    Cash from financing

    -$5.76M
    BCRX annual cash flow from financing activities is -$5.76 million

    Cash from financing 1-year change

    -117.73%
    BCRX annual cash flow from financing activities is down -117.73% year-on-year

    CAPEX

    CAPEX

    $1.12M
    BCRX annual capital expenditures is $1.12 million

    CAPEX 1-year change

    -48.15%
    BCRX annual capital expenditures is down -48.15% year-on-year

    Free Cash Flow

    Free cash flow

    -$53.14M
    BCRX annual free cash flow is -$53.14 million

    Free cash flow 1-year change

    +45.39%
    BCRX annual free cash flow is up +45.39% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    97.23%
    BCRX annual gross profit margin is 97.23%

    Operating margin

    -0.56%
    BCRX annual operating profit margin is -0.56%

    Net margin

    -19.72%
    BCRX annual net profit margin is -19.72%

    ROA & ROE

    ROA

    -17.65%
    BCRX annual return on assets is -17.65%

    ROE

    18.68%
    BCRX annual return on equity is 18.68%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    BCRX price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    BCRX price to earnings ratio is unknown

    PB Ratio

    PB ratio

    -4.06
    BCRX price to book ratio is -4.06

    PB ratio Sector rank

    5.87%
    BCRX price to book ratio is higher than 5.87% of companies in Healthcare sector

    PS Ratio

    PS ratio

    3.64
    BCRX price to sales ratio is 3.64

    PS ratio Sector rank

    54.69%
    BCRX price to sales ratio is higher than 54.69% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $2.52B
    BCRX enterprise value is $2.52 billion

    Enterprise value Sector rank

    83.17%
    BCRX enterprise value is higher than 83.17% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    53.01
    BCRX EV/EBITDA is 53.01

    EV/EBITDA Sector rank

    97.19%
    BCRX EV/EBITDA is higher than 97.19% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    2.63
    BCRX annual current ratio is 2.63

    Quick ratio

    2.58
    BCRX annual quick ratio is 2.58

    Leverage

    Debt to equity

    -1.67
    BCRX annual debt to equity ratio is -1.67

    Interest coverage ratio

    0.12
    BCRX annual interest coverage ratio is 0.12

    Risk & Stability

    Piotroski F-Score

    3
    BCRX piotroski f-score is 3

    Altman Z-Score

    -2.28
    BCRX altman z-score is -2.28

    Analyst ratings

    Recent major analysts updates

    Jul 1, 25 B of A Securities
    Buy
    Jun 30, 25 Wedbush
    Outperform
    Jun 30, 25 RBC Capital
    Outperform
    Jun 27, 25 Needham
    Buy
    Jun 25, 25 Needham
    Buy
    May 7, 25 Barclays
    Equal-Weight
    May 6, 25 RBC Capital
    Outperform
    May 6, 25 Needham
    Buy
    May 6, 25 JP Morgan
    Overweight
    May 6, 25 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with BCRX included

    Growing Shares Outstanding
    US stocks
    Most recommended stocks
    Best performing stocks last 3 months
    Best performing stocks last 5 years
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for BioCryst Pharmaceuticals, Inc.?
    • Does BioCryst Pharmaceuticals, Inc. pay dividends?
    • What sector is BioCryst Pharmaceuticals, Inc. in?
    • What industry is BioCryst Pharmaceuticals, Inc. in?
    • What country is BioCryst Pharmaceuticals, Inc. based in?
    • When did BioCryst Pharmaceuticals, Inc. go public?
    • Is BioCryst Pharmaceuticals, Inc. in the S&P 500?
    • Is BioCryst Pharmaceuticals, Inc. in the NASDAQ 100?
    • Is BioCryst Pharmaceuticals, Inc. in the Dow Jones?
    • When was BioCryst Pharmaceuticals, Inc.'s last earnings report?
    • When does BioCryst Pharmaceuticals, Inc. report earnings?

    What is the ticker symbol for BioCryst Pharmaceuticals, Inc.?

    The ticker symbol for BioCryst Pharmaceuticals, Inc. is NASDAQ:BCRX

    Does BioCryst Pharmaceuticals, Inc. pay dividends?

    No, BioCryst Pharmaceuticals, Inc. does not pay dividends

    What sector is BioCryst Pharmaceuticals, Inc. in?

    BioCryst Pharmaceuticals, Inc. is in the Healthcare sector

    What industry is BioCryst Pharmaceuticals, Inc. in?

    BioCryst Pharmaceuticals, Inc. is in the Drug Manufacturers - Specialty & Generic industry

    What country is BioCryst Pharmaceuticals, Inc. based in?

    BioCryst Pharmaceuticals, Inc. is headquartered in United States

    When did BioCryst Pharmaceuticals, Inc. go public?

    BioCryst Pharmaceuticals, Inc.'s initial public offering (IPO) was on March 4, 1994

    Is BioCryst Pharmaceuticals, Inc. in the S&P 500?

    No, BioCryst Pharmaceuticals, Inc. is not included in the S&P 500 index

    Is BioCryst Pharmaceuticals, Inc. in the NASDAQ 100?

    No, BioCryst Pharmaceuticals, Inc. is not included in the NASDAQ 100 index

    Is BioCryst Pharmaceuticals, Inc. in the Dow Jones?

    No, BioCryst Pharmaceuticals, Inc. is not included in the Dow Jones index

    When was BioCryst Pharmaceuticals, Inc.'s last earnings report?

    BioCryst Pharmaceuticals, Inc.'s most recent earnings report was on May 5, 2025

    When does BioCryst Pharmaceuticals, Inc. report earnings?

    The next expected earnings date for BioCryst Pharmaceuticals, Inc. is August 5, 2025
    On this page